CJC-1295 + Ipamorelin Blend 10mg
A pre-blended combination of CJC-1295 no DAC (a GHRH analog) and Ipamorelin (a selective ghrelin receptor agonist). Research demonstrates synergistic GH release when GHRH and GHRP pathways are stimulated simultaneously, producing significantly greater GH output than either compound alone.
Sequence
Blend: CJC-1295 no DAC (5mg) + Ipamorelin (5mg) per vial
Market avg: $69.99 — save 40%
Volume pricing
Pay with USDC via Coinbase Commerce
Certificate of Analysis
Independently verified by Janoshik Analytical
Test ID
JAN-CJCIPAM-2026-001
Purity
99.1%
Method
HPLC-MS
Batch
CJCIPAM-2026-01A
Test Date
February 1, 2026
Identity
Confirmed
Endotoxin
<0.5 EU/mg
Storage Requirements
Lyophilized
2-8°C, protect from light
Reconstituted
2-8°C, use within 21 days
Most popular GH secretagogue combination. Reconstitute with bacteriostatic water.
Published Research
2 peer-reviewed studies
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295
Teichman SL, Neale A, Lawrence B, et al. — Journal of Clinical Endocrinology & Metabolism, 2006
Clinical study on CJC-1295 GH stimulation.
Ipamorelin, the first selective growth hormone secretagogue
Raun K, Hansen BS, Johansen NL, et al. — European Journal of Endocrinology, 1998
Original characterization of ipamorelin selectivity.
Related Products
Research use only. All products are sold strictly for in-vitro research purposes only. Not for human consumption. Information provided references published research literature. No medical claims are made or implied.